181 related articles for article (PubMed ID: 35093283)
1. Understanding of medications and associations with adherence, unmet needs, and perceived control of risk factors at two years post-stroke.
Dalli LL; Andrew NE; Kim J; Cadilhac DA; Sanfilippo FM; Thrift AG; Nelson MR; Lannin NA; Olaiya MT; Ryan OF; Booth B; Gall S; Kilkenny MF;
Res Social Adm Pharm; 2022 Sep; 18(9):3542-3549. PubMed ID: 35093283
[TBL] [Abstract][Full Text] [Related]
2. Greater Adherence to Secondary Prevention Medications Improves Survival After Stroke or Transient Ischemic Attack: A Linked Registry Study.
Dalli LL; Kim J; Cadilhac DA; Greenland M; Sanfilippo FM; Andrew NE; Thrift AG; Grimley R; Lindley RI; Sundararajan V; Crompton DE; Lannin NA; Anderson CS; Whiley L; Kilkenny MF
Stroke; 2021 Nov; 52(11):3569-3577. PubMed ID: 34315251
[TBL] [Abstract][Full Text] [Related]
3. The effect of a locally adapted, secondary stroke risk factor self-management program on medication adherence among veterans with stroke/TIA.
Damush TM; Myers L; Anderson JA; Yu Z; Ofner S; Nicholas G; Kimmel B; Schmid AA; Kent T; Williams LS
Transl Behav Med; 2016 Sep; 6(3):457-68. PubMed ID: 27349906
[TBL] [Abstract][Full Text] [Related]
4. Under-prescribing of Prevention Drugs and Primary Prevention of Stroke and Transient Ischaemic Attack in UK General Practice: A Retrospective Analysis.
Turner GM; Calvert M; Feltham MG; Ryan R; Fitzmaurice D; Cheng KK; Marshall T
PLoS Med; 2016 Nov; 13(11):e1002169. PubMed ID: 27846215
[TBL] [Abstract][Full Text] [Related]
5. Concerns about medications mediate the association of posttraumatic stress disorder with adherence to medication in stroke survivors.
Edmondson D; Horowitz CR; Goldfinger JZ; Fei K; Kronish IM
Br J Health Psychol; 2013 Nov; 18(4):799-813. PubMed ID: 23294320
[TBL] [Abstract][Full Text] [Related]
6. Trials to improve blood pressure through adherence to antihypertensives in stroke/TIA: systematic review and meta-analysis.
De Simoni A; Hardeman W; Mant J; Farmer AJ; Kinmonth AL
J Am Heart Assoc; 2013 Aug; 2(4):e000251. PubMed ID: 23963756
[TBL] [Abstract][Full Text] [Related]
7. Persistence of secondary prevention medication and related factors for acute ischemic stroke and transient ischemic attack in China.
Jiang Y; Yang X; Li Z; Pan Y; Wang Y; Wang Y; Ji R; Wang C
Neurol Res; 2017 Jun; 39(6):492-497. PubMed ID: 28420316
[TBL] [Abstract][Full Text] [Related]
8. Patterns of Use and Discontinuation of Secondary Prevention Medications After Stroke.
Dalli LL; Kim J; Thrift AG; Andrew NE; Sanfilippo FM; Lopez D; Grimley R; Lannin NA; Wong L; Lindley RI; Campbell BCV; Anderson CS; Cadilhac DA; Kilkenny MF;
Neurology; 2021 Jan; 96(1):e30-e41. PubMed ID: 33093227
[TBL] [Abstract][Full Text] [Related]
9. Treatment with Multiple Therapeutic Classes of Medication Is Associated with Survival after Stroke.
Kilkenny MF; Olaiya MT; Dalli LL; Kim J; Andrew NE; Sanfilippo FM; Thrift AG; Nelson M; Pearce C; Sanders L; Dewey H; Clissold B; Grimley R; Cadilhac DA
Neuroepidemiology; 2022; 56(1):66-74. PubMed ID: 34758474
[TBL] [Abstract][Full Text] [Related]
10. Medicines taken by older Australians after transient ischaemic attack or ischaemic stroke: a retrospective database study.
Sluggett JK; Caughey GE; Ward MB; Gilbert AL
Int J Clin Pharm; 2015 Oct; 37(5):782-9. PubMed ID: 25920907
[TBL] [Abstract][Full Text] [Related]
11. Cognitive impairment and medication adherence post-stroke: A five-year follow-up of the ASPIRE-S cohort.
Rohde D; Gaynor E; Large M; Mellon L; Bennett K; Williams DJ; Brewer L; Hall P; Callaly E; Dolan E; Hickey A
PLoS One; 2019; 14(10):e0223997. PubMed ID: 31622438
[TBL] [Abstract][Full Text] [Related]
12. Key barriers to medication adherence in survivors of strokes and transient ischemic attacks.
Kronish IM; Diefenbach MA; Edmondson DE; Phillips LA; Fei K; Horowitz CR
J Gen Intern Med; 2013 May; 28(5):675-82. PubMed ID: 23288379
[TBL] [Abstract][Full Text] [Related]
13. Secondary-prevention drug prescription in the very elderly after ischemic stroke or TIA.
Ovbiagele B; Hills NK; Saver JL; Johnston SC
Neurology; 2006 Feb; 66(3):313-8. PubMed ID: 16476928
[TBL] [Abstract][Full Text] [Related]
14. Assuming one dose per day yields a similar estimate of medication adherence in patients with stroke: An exploratory analysis using linked registry data.
Ung D; Dalli LL; Lopez D; Sanfilippo FM; Kim J; Andrew NE; Thrift AG; Cadilhac DA; Anderson CS; Kilkenny MF
Br J Clin Pharmacol; 2021 Mar; 87(3):1089-1097. PubMed ID: 32643250
[TBL] [Abstract][Full Text] [Related]
15. Processes of Care Associated With Risk of Mortality and Recurrent Stroke Among Patients With Transient Ischemic Attack and Nonsevere Ischemic Stroke.
Bravata DM; Myers LJ; Reeves M; Cheng EM; Baye F; Ofner S; Miech EJ; Damush T; Sico JJ; Zillich A; Phipps M; Williams LS; Chaturvedi S; Johanning J; Yu Z; Perkins AJ; Zhang Y; Arling G
JAMA Netw Open; 2019 Jul; 2(7):e196716. PubMed ID: 31268543
[TBL] [Abstract][Full Text] [Related]
16. Racial differences in persistence to secondary prevention medication regimens after ischemic stroke.
Sheehan OC; Dhamoon MS; Bettger JP; Huang J; Liu C; Rhodes JD; Clay OJ; Roth DL
Ethn Health; 2022 Oct; 27(7):1671-1683. PubMed ID: 34196573
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive and Lipid-Lowering Medication Adherence in Young Adults With Youth-Onset Type 2 Diabetes.
Weinstock RS; Trief PM; Burke BK; Wen H; Liu X; Kalichman S; Anderson BJ; Bulger JD
JAMA Netw Open; 2023 Oct; 6(10):e2336964. PubMed ID: 37792373
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive Medication Adherence and the Risk of Vascular Events and Falls After Stroke: A Real-World Effectiveness Study Using Linked Registry Data.
Dalli LL; Olaiya MT; Kim J; Andrew NE; Cadilhac DA; Ung D; Lindley RI; Sanfilippo FM; Thrift AG; Nelson MR; Gall SL; Kilkenny MF;
Hypertension; 2023 Jan; 80(1):182-191. PubMed ID: 36330805
[TBL] [Abstract][Full Text] [Related]
19. Real-World Effectiveness of Lipid-Lowering Medications on Outcomes after Stroke: Potential Implications of the New-User Design.
Olaiya MT; Andrew NE; Dalli LL; Ung D; Kim J; Cadilhac DA; Wood P; May J; Clissold B; Kilkenny MF;
Neuroepidemiology; 2022; 56(5):365-372. PubMed ID: 35863320
[TBL] [Abstract][Full Text] [Related]
20. Use of secondary stroke prevention medicines in Australia: national trends, 2003-2009.
Sluggett JK; Caughey GE; Ward MB; Gilbert AL
Med J Aust; 2014 Jul; 201(1):54-7. PubMed ID: 24999900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
